We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths

    Purpose

    Understanding how stage at cancer diagnosis influences cause of death, an endpoint that is not susceptible to lead-time bias, can inform...

    Ellen T. Chang, Christina A. Clarke, ... Earl Hubbell in Cancer Causes & Control
    Article Open access 18 January 2024
  2. Immediate risk of non-cancer deaths after a cancer diagnosis

    Background

    Receiving a cancer diagnosis may trigger immediate fatal non-cancer health outcomes in addition to dying of cancer itself. We aim to...

    Pengcheng Yang, Yongqiang Zheng, ... Bian Wu in BMC Cancer
    Article Open access 27 August 2021
  3. Molecular Insights and Risk Factors Associated with Small and Non-small Cell Lung Cancer

    With approximately two million new cases and 1.76 million deaths annually, lung cancer is one of the most commonly found malignancies and the main...
    Madhu Sharma, Sweety Mehra, ... Mani Chopra in Molecular Biomarkers for Cancer Diagnosis and Therapy
    Chapter 2024
  4. Modulation of Long Non-coding RNAs in Cancer

    Cancer is associated to uncontrolled growth of cells. It is the second most common cause of death worldwide. Main treatment consists of surgery,...
    Glenda Nicioli da Silva, LĂ­via da Cunha Agostini, Tamires Cunha Almeida in Handbook of Cancer and Immunology
    Living reference work entry 2024
  5. Proportion of cancer cases and deaths attributable to potentially modifiable risk factors in Peru

    Background

    Limited evidence exists on the population attributable fraction (PAF) of cancer cases and deaths in Latin America. In Peru several studies...

    Jhony A. De La Cruz-Vargas, Willy Ramos, ... Diego Venegas in BMC Cancer
    Article Open access 15 April 2024
  6. Do Marine Polysaccharides Carrageenans Modulate Non-apoptotic Regulated Cell Deaths ? (a Review)

    Purpose of Review

    A growing number of studies indicate that a network of regulated cell death (RCD) pathways plays a vital role in tumorigenesis...

    Anton Tkachenko, Anatolii Onishchenko, Volodymyr Prokopiuk in Current Pharmacology Reports
    Article 04 September 2023
  7. Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers

    Lung cancer is the primary contributor to cancer-related deaths globally, and non-small cell lung cancer (NSCLC) constitutes around 85% of all lung...

    Hongge Liang, Yan Xu, ... Mengzhao Wang in Cancer Gene Therapy
    Article Open access 18 March 2024
  8. Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives

    Cervical cancer is among the leading causes of cancer-associated mortality in women. In spite of vaccine availability, improved screening procedures,...

    Shalu Ranga, Ritu Yadav, ... Parul Ahuja in Apoptosis
    Article 25 April 2023
  9. Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer

    Background

    Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related deaths worldwide, primarily due to its propensity for...

    Bin Luo, Zujun Que, ... Jianhui Tian in Biological Procedures Online
    Article Open access 13 November 2023
  10. Non B Cell-Derived Immunoglobulins in Lung Epithelial Cells and Lung Cancer

    As the locus for air exchange, lung tissue is perpetually exposed to a significant quantity of foreign pathogens. Consequently, lung has developed a...
    **gshu Tang, Erya Gao, ... Wenwei Shao in Non B cell-Derived Immunoglobulins
    Chapter 2024
  11. Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a sco** review

    Minocycline is an FDA-approved secondary-generation tetracycline antibiotic. It is a synthetic antibiotic having many biological effects, such as...

    Abedeh Rezaei, Amin Moqadami, Mohammad Khalaj-Kondori in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 22 November 2023
  12. Paraptosis: a non-classical paradigm of cell death for cancer therapy

    Due to the sustained proliferative potential of cancer cells, inducing cell death is a potential strategy for cancer therapy. Paraptosis is a mode of...

    Chun-cao Xu, Yi-fan Lin, ... **-jian Lu in Acta Pharmacologica Sinica
    Article 15 September 2023
  13. Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

    Background

    With the application of immune checkpoint inhibitors (ICIs) in cancer treatment, more and more attention has been paid to checkpoint...

    Li Pang, Mei **e, ... **nying Xue in BMC Cancer
    Article Open access 03 March 2023
  14. LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling

    Lung cancer is the leading cause of cancer-related deaths worldwide. Long non-coding RNAs (lncRNAs) have emerged as key regulators of cancer...

    Qiurong Yang, Maoye Wang, ... Xu Zhang in Molecular Cancer
    Article Open access 04 August 2023
  15. Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study

    Background

    To analyze the efficacy of stereotactic ablative brachytherapy (SABT) and percutaneous microwave ablation (MWA) for the treatment of...

    Chuanwang Wu, Binglong Cao, ... Wujie Wang in BMC Cancer
    Article Open access 06 March 2024
  16. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro

    Lung cancer is the second most prevalent type of cancer and is responsible for the highest number of cancer-related deaths worldwide. Non-small-cell...

    Bikash Manandhar, Keshav Raj Paudel, ... Kamal Dua in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 13 July 2023
  17. ACADL-YAP axis activity in non-small cell lung cancer carcinogenicity

    Background

    The role of Acyl-CoA dehydrogenase long chain (ACADL) in different tumor types had different inhibiting or promoting effect. However, its...

    Kegong Chen, Chunqiao Hong, ... Renquan Zhang in Cancer Cell International
    Article Open access 24 February 2024
  18. A population-based cohort study on changes in breast, lung and colorectal cancer incidence and mortality among non-Western immigrant women

    Background

    Cancer risk varies geographically, and migrants are influenced by different risk factors before, during and after migration. Increased...

    Maarit Lamminmäki, Aku Leivonen, ... Tytti Sarkeala in BMC Cancer
    Article Open access 14 July 2023
  19. Immunotherapy for Non-small Cell Lung Cancer

    The introduction of immunotherapies in the treatment of metastatic lung cancer has brought a major change to oncology practices with a high impact on...
    Fabrizio Minervini, Laura Boschetti, Esther Pardo in Handbook of Cancer and Immunology
    Living reference work entry 2023
  20. Large-scale pancreatic cancer detection via non-contrast CT and deep learning

    Pancreatic ductal adenocarcinoma (PDAC), the most deadly solid malignancy, is typically detected late and at an inoperable stage. Early or incidental...

    Kai Cao, Yingda ** Lu in Nature Medicine
    Article Open access 20 November 2023
Did you find what you were looking for? Share feedback.